期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

系统性红斑狼疮致重症肺炎一例 被引量：1

原文传递
导出
摘要 患者女，26岁，2012年2月17日发热，伴寒战，体温最高38．5℃，在当地诊断上呼吸道感染，给予抗病毒及对症治疗3d无效。3d后出现咳嗽，咳白色泡沫痰，偶痰中带血，
作者 李羽 谢华宁 张岩
机构地区 第四军医大学唐都医院风湿免疫科
出处 《中华临床医师杂志（电子版）》 CAS 2013年第20期139-140,共2页 Chinese Journal of Clinicians(Electronic Edition)
关键词 系统性红斑狼疮 重症肺炎 上呼吸道感染 对症治疗 痰中带血 抗病毒 泡沫痰
分类号 R593.241 [医药卫生—内科学]
  • 相关文献

参考文献10

  • 1Morgenthaler NG,Struck J,Chancerelle Y. Production of procalcitonin(PCT)in nonthyroidal tissue after LPS injection[J].{H}HORMONE AND METABOLIC RESEARCH,2003.290-295.
  • 2Assicot M,Gendrel D,Carsin H. High serum procalcitonin concentrations in patients with sepsis and infection[J].{H}LANCET,1993.515-518.
  • 3王珊,刘双.血清降钙素原在肺炎诊断及严重程度判断中的研究[J].心肺血管病杂志,2012,31(3):273-277. 被引量：28
  • 4Memet B,Ginzler EM. Pulmonary Manifestations of Systemic Lupus Erythematosus[J].{H}Seminars in respiratory and critical care medicine,2007.441-450.
  • 5Kamen DL,Strange C. Pulmonary manifestations of systemic lupus erythematosus[J].{H}CLINICS IN CHEST MEDICINE,2010.479-488.
  • 6Murin S,Wiedemann HP,Matthay RA. Pulmonary manifestations of systemic lupus erythematosus[J].{H}CLINICS IN CHEST MEDICINE,1998.641-665.
  • 7Pego-Reigosa JM,Medeiros DA,Isenberg DA. Respiratory manifestations of systemic lupus erythematosus:Old and new concepts[J].Best Pract Res Clin Rheumato,2009.469-480.
  • 8Lynch DA. Lung disease related to collagen vascular disease[J].{H}Journal of Thoracic Imaging,2009.299-309.
  • 9Lim W,Crowther MA,Eikelboom JW. Management of antiphospholipid antibody syndrome:a systematic review[J].{H}JAMA:the Journal of the American Medical Association,2006.1050-1057.
  • 10Wu JY,Lee SH,Shen CJ. Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases:A systemic review and meta-analysis[J].{H}ARTHRITIS AND RHEUMATISM,2012.3034-3042.

二级参考文献21

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量：3052
  • 2Sharma S,Maycher B,Eschun G.Radiological imaging in pneu-monia:recent innovations.Curr Opin.Pulm Med,2007,13:159-169.
  • 3Qu JM,Summah H.Biomarkers:a definite plus in pneumonia.Mediators Inflamm,2009:675-753.
  • 4Morgenthaler NG,Struck J,Chancerelle Y,et al.Production ofprocalcitonin(PCT)in nonthyroidal tissue after LPS injection.Horm Metab Res,2003,35:290-295.
  • 5Assicot M,Gendrel D,Carsin H,et al.High serum procalcitoninconcentrations in patients with sepsis and infection.Lancet,1993,341:515-518.
  • 6Silvestri L,Van Saene H K F,De La Cal MA,et al.Adult hospitaland ventilator-associated pneumonia guidelines:Eminence-ratherthan evidence-based.Am J Respir Crit Care Med,2006,173:131-133.
  • 7Neill AM,Martin IR,Weir R,et al.Community acquired pneu-monia:aetiology and usefulness of severity criteria on admission.Thorax,1996,51:1010-1016.
  • 8Lim WS,van der Eerden MM,Laing R,et al.Defining commu-nity acquired pneumonia severity on presentation to hospital:aninternational derivation and validation study.Thorax,2003,58:377-382.
  • 9Krüger S,Ewig S.Papassotiriou J.et al.Inflammatory parame-ters predict etiologic patterns but do not allow for individual pre-diction of etiology in patients with CAP:results from the Germancompetence network CAPNETZ.Respir Res,2009,10:65.
  • 10MasiáM,Félix G,Conrado S,et al.Usefulness of procalcitoninlevels in community-acquired pneumonia according to the patientsoutcome research team pneumonia severity index.Chest,2005,128:2223-2229.

共引文献27

同被引文献10

引证文献1

中华临床医师杂志（电子版）
2013年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部